• Non-Surgical Metabolic Control
• Limitations of Current Treatment
• Limitations of Surgery
• An Innovative Solution

Limitations of Surgery

Although gastric bypass surgery is viewed by some members of the medical community as a viable option for patients with type 2 diabetes and obesity, there are only about 175,000 gastric bypass surgeries performed per year in the United States. This represents just one percent of the candidate obese population.

Patient reluctance to undergo gastric bypass can be attributed to fear of such a dramatic anatomy-altering, non-reversible, permanent surgery. The risk of short- and long-term complications such as infection, pulmonary embolism, nutritional deficiencies and hyperinsulinemic hypoglycemia also contribute to the fear associated with gastric bypass surgery. For all of these reasons, patients and physicians are seeking breakthrough approaches to address type 2 diabetes and obesity.